Senestech PE Ratio 2015-2023 | SNES
Current and historical p/e ratio for Senestech (SNES) from 2015 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Senestech PE ratio as of May 10, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Senestech PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-10 | 0.68 | 0.00 | |
| 2023-12-31 | 1.27 | $-29.89 | 0.00 |
| 2023-09-30 | 5.04 | $-29.89 | 0.00 |
| 2023-06-30 | 13.44 | $-77.07 | 0.00 |
| 2023-03-31 | 17.88 | $-119.09 | 0.00 |
| 2022-12-31 | 37.08 | $-148.86 | 0.00 |
| 2022-09-30 | 84.12 | $-199.28 | 0.00 |
| 2022-06-30 | 126.58 | $-189.68 | 0.00 |
| 2022-03-31 | 175.20 | $-163.27 | 0.00 |
| 2021-12-31 | 234.91 | $-170.47 | 0.00 |
| 2021-09-30 | 362.40 | $-206.48 | 0.00 |
| 2021-06-30 | 386.40 | $-297.72 | 0.00 |
| 2021-03-31 | 398.40 | $-415.37 | 0.00 |
| 2020-12-31 | 414.00 | $-768.31 | 0.00 |
| 2020-09-30 | 451.20 | $-681.87 | 0.00 |
| 2020-06-30 | 480.00 | $-979.59 | 0.00 |
| 2020-03-31 | 496.80 | $-1,270.11 | 0.00 |
| 2019-12-31 | 2640.00 | $-1,344.54 | 0.00 |
| 2019-09-30 | 4848.00 | $-1,824.73 | 0.00 |
| 2019-06-30 | 8640.00 | $-2,064.83 | 0.00 |
| 2019-03-31 | 5856.00 | $-2,833.13 | 0.00 |
| 2018-12-31 | 2808.96 | $-3,121.25 | 0.00 |
| 2018-09-30 | 3312.00 | $-3,361.34 | 0.00 |
| 2018-06-30 | 7824.00 | $-4,033.61 | 0.00 |
| 2018-03-31 | 2448.00 | $-4,513.81 | 0.00 |
| 2017-12-31 | 3456.00 | $-5,378.15 | 0.00 |
| 2017-09-30 | 8880.00 | $-4,657.86 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.005B | $0.001B |
| SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.087B | 23.84 |
| Stryker (SYK) | United States | $126.041B | 30.19 |
| Medtronic (MDT) | Ireland | $109.891B | 15.56 |
| Boston Scientific (BSX) | United States | $108.712B | 34.63 |
| EssilorLuxottica (ESLOY) | France | $100.718B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.251B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.716B | 27.53 |
| ResMed (RMD) | United States | $31.855B | 29.91 |
| Terumo (TRUMY) | Japan | $25.103B | 35.45 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.984B | 15.96 |
| Koninklijke Philips (PHG) | Netherlands | $24.498B | 18.98 |
| Baxter (BAX) | United States | $18.319B | 13.02 |
| Insulet (PODD) | United States | $12.431B | 55.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.955B | 0.00 |
| Demant (WILYY) | Denmark | $10.100B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.908B | 25.87 |
| BellRing Brands (BRBR) | United States | $7.758B | 36.34 |
| Lantheus Holdings (LNTH) | United States | $5.261B | 13.11 |
| Haemonetics (HAE) | United States | $4.703B | 23.27 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.229B | 12.82 |
| Prestige Consumer Healthcare (PBH) | United States | $3.491B | 16.51 |
| Envista Holdings (NVST) | United States | $3.313B | 13.67 |
| QuidelOrtho (QDEL) | United States | $2.917B | 16.22 |
| Green Thumb Industries (GTBIF) | United States | $2.695B | 53.38 |
| Neogen (NEOG) | United States | $2.692B | 25.90 |
| TG Therapeutics (TGTX) | United States | $2.615B | 73.57 |
| ICU Medical (ICUI) | United States | $2.592B | 22.88 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.479B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.869B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.741B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.706B | 50.00 |
| InMode (INMD) | Israel | $1.542B | 8.20 |
| Warby Parker (WRBY) | United States | $1.455B | 0.00 |
| Owens & Minor (OMI) | United States | $1.406B | 12.25 |
| AdaptHealth (AHCO) | United States | $1.221B | 9.10 |
| National Vision Holdings (EYE) | United States | $1.190B | 37.88 |
| AtriCure (ATRC) | United States | $1.047B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.999B | 0.00 |
| MacroGenics (MGNX) | United States | $0.918B | 0.00 |
| Evolus (EOLS) | United States | $0.822B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.816B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.717B | 15.26 |
| Cresco Labs (CRLBF) | United States | $0.706B | 0.00 |
| Quanterix (QTRX) | United States | $0.655B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.650B | 15.28 |
| PetIQ (PETQ) | United States | $0.550B | 17.97 |
| Jin Medical (ZJYL) | China | $0.504B | 0.00 |
| Valneva SE (VALN) | France | $0.496B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.496B | 0.00 |
| Biote (BTMD) | United States | $0.466B | 8.93 |
| ZimVie (ZIMV) | United States | $0.463B | 39.47 |
| Surmodics (SRDX) | United States | $0.461B | 28.86 |
| OraSure Technologies (OSUR) | United States | $0.386B | 12.01 |
| Aurora Cannabis (ACB) | Canada | $0.371B | 0.00 |
| Cerus (CERS) | United States | $0.353B | 0.00 |
| Zynex (ZYXI) | United States | $0.329B | 44.96 |
| Sanara MedTech (SMTI) | United States | $0.286B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 27.42 |
| TriSalus Life Sciences (TLSI) | United States | $0.262B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.249B | 15.43 |
| Omeros (OMER) | United States | $0.206B | 0.00 |
| Veru (VERU) | United States | $0.201B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.185B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.171B | 0.00 |
| InterCure (INCR) | Israel | $0.150B | 25.31 |
| Eagleford Energy (GRUSF) | United States | $0.140B | 70.49 |
| FitLife Brands (FTLF) | United States | $0.138B | 22.26 |
| Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.116B | 0.00 |
| Fonar (FONR) | United States | $0.111B | 9.50 |
| MariMed (MRMD) | United States | $0.103B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Brainsway (BWAY) | Israel | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.091B | 0.00 |
| Safety Shot (SHOT) | United States | $0.064B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.063B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.061B | 3.95 |
| Apyx Medical (APYX) | United States | $0.058B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Bright Green (BGXX) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.29 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Agape ATP (ATPC) | $0.022B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.50 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |